Lin, L., van der Meer, E. K. O., Steeghs, N., Beijnen, J. H., & Huitema, A. D. R. (2024). Are novel oral oncolytics underdosed in obese patients? Cancer Chemotherapy and Pharmacology, 93(2), 129-136. https://doi.org/10.1007/s00280-023-04601-z
Chicago Style (17th ed.) CitationLin, Lishi, Ellen K. O. van der Meer, Neeltje Steeghs, Jos H. Beijnen, and Alwin D. R. Huitema. "Are Novel Oral Oncolytics Underdosed in Obese Patients?" Cancer Chemotherapy and Pharmacology 93, no. 2 (2024): 129-136. https://doi.org/10.1007/s00280-023-04601-z.
MLA (9th ed.) CitationLin, Lishi, et al. "Are Novel Oral Oncolytics Underdosed in Obese Patients?" Cancer Chemotherapy and Pharmacology, vol. 93, no. 2, 2024, pp. 129-136, https://doi.org/10.1007/s00280-023-04601-z.